Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients.
Ann Oncol
; 22(9): 2073-2079, 2011 Sep.
Article
in En
| MEDLINE
| ID: mdl-21310760
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyrimidines
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Acute Kidney Injury
/
Kidney Failure, Chronic
/
Antineoplastic Agents
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2011
Document type:
Article